1-12 of 12
Authors: Haipeng Tao
Journal Article
IMMU-21. OVEREXPRESSING CAR T-CELL GLUCOSE TRANSPORTER TO ENHANCE ANTI-TUMOR ACTIVITY IN GLIOBLASTOMA
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii156–viii157, https://doi.org/10.1093/neuonc/noae165.0614
Published: 11 November 2024
Journal Article
EXTH-58. BLOCKING IMMUNE CHECKPOINT— LAIR1: DISRUPTING THE LAIR1—FXIII-A—COLLAGEN IMMUNOSUPPRESSIVE CIRCUIT FOR ENHANCED ANTITUMOR THERAPEUTICS
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii250, https://doi.org/10.1093/neuonc/noae165.0989
Published: 11 November 2024
Journal Article
CTIM-21. FIRST-IN-HUMAN PHASE I CLINICAL TRIAL USING 8R-70CAR T CELLS FOR NEWLY DIAGNOSED ADULT GLIOBLASTOMA
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii90, https://doi.org/10.1093/neuonc/noae165.0354
Published: 11 November 2024
Journal Article
EXTH-22. AN IND-ENABLED STUDY USING A NOVEL CHECKPOINT BLOCKADE OF LAIR1 FOR GLIOBLASTOMA THERAPY
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v228, https://doi.org/10.1093/neuonc/noad179.0875
Published: 10 November 2023
Journal Article
EXTH-57. IDENTIFICATION OF NOVEL IMMUNE CHECKPOINT MOLECULE IN GLIOMA, LAIR1
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii222, https://doi.org/10.1093/neuonc/noac209.855
Published: 14 November 2022
Journal Article
CBIO-16. DOSE INTENSIFIED TEMOZOLOMIDE IMPROVES INFILTRATION OF CD70 CAR T CELLS INTO THE GBM TUMOR MICROENVIRONMENT
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi30, https://doi.org/10.1093/neuonc/noab196.116
Published: 12 November 2021
Journal Article
IMMU-38. PRECLINICAL VALIDATION AND MANUFACTURE OF IL-8 RECEPTOR-MODIFIED CD70 CAR T CELLS FOR CLINICAL TRIAL
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii113, https://doi.org/10.1093/neuonc/noaa215.468
Published: 09 November 2020
Journal Article
IMMU-15. A UNIQUE SELF-STIMULATIVE PROPERTY OF CD70 CAR ADVANCES T CELL FUNCTION AND ANTI-TUMOR RESPONSE IN GLIOBLASTOMA
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi122, https://doi.org/10.1093/neuonc/noz175.509
Published: 11 November 2019
Journal Article
IMMU-26. RADIATION AND TEMOZOLOMIDE UP-REGULATES CD70 EXPRESSION AND ENHANCES CAR T- CELL RECOGNITION IN GBM
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi124, https://doi.org/10.1093/neuonc/noz175.519
Published: 11 November 2019
Journal Article
TMIC-49. ABROGATING CD70 EXPRESSION IN GBM RESULTS IN A REDUCED IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi258, https://doi.org/10.1093/neuonc/noz175.1083
Published: 11 November 2019
Journal Article
IMMU-56. CXCR1/2 MODIFIED CARs CO-OPT RADIATION-INDUCED IL-8 FOR ENHANCED CHEMOTAXIS OF THE CAR T CELLS AND MAXIMAL ANTI-TUMOR EFFICACY
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi134, https://doi.org/10.1093/neuonc/noy148.559
Published: 05 November 2018
Journal Article
DRES-13. VEGF BLOCKADE ENHANCES T REGULATORY CELL FUNCTION BY DYSREGULATING GLUTAMATE TRANSPORT IN GBM
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi78, https://doi.org/10.1093/neuonc/noy148.320
Published: 05 November 2018
